2-(tert-butoxymethyl)propan-1,3-diol | 213011-49-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(tert-butoxymethyl)propan-1,3-diol
• 英文别名: 2-tert-Butoxymethyl-propane-1,3-diol；2-[(2-methylpropan-2-yl)oxymethyl]propane-1,3-diol
• CAS: 213011-49-5
• 化学式: C₈H₁₈O₃
• 分子量: 162.229
• InChiKey: WEUBXYYMPLOVJY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(tert-butoxymethyl)propan-1,3-diol 在 吡啶 、 lithium aluminium tetrahydride 、 pseudomonas fluorescens lipase 、 pH=7 buffer 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 31.68h， 生成 Methanesulfonic acid (S)-3-tert-butoxy-2-methyl-propyl ester
  参考文献：
  名称：

  Asymmetrization of meso-1,3-diols utilising Pseudomonas fluorescens lipase

  摘要：

  A convenient and enantioselective synthesis of monoacetates of meso-1,3-diols 2-substituted with an alkoxymethyl or a thiophenylmethyl group, by enzyme catalyzed acylation, is described. The absolute stereochemistries of two monoacetates were assigned by chemical correlation. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(98)00237-7
• 作为产物：
  描述：

  2-[(tert-butoxy)methyl]malonic acid diethyl ester 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 17.0h， 以71%的产率得到2-(tert-butoxymethyl)propan-1,3-diol
  参考文献：
  名称：

  Asymmetrization of meso-1,3-diols utilising Pseudomonas fluorescens lipase

  摘要：

  A convenient and enantioselective synthesis of monoacetates of meso-1,3-diols 2-substituted with an alkoxymethyl or a thiophenylmethyl group, by enzyme catalyzed acylation, is described. The absolute stereochemistries of two monoacetates were assigned by chemical correlation. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(98)00237-7

文献信息

• N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS
  申请人：SANOFI

  公开号：US20160024097A1

  公开（公告）日：2016-01-28

  The present invention relates to N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides of the formula I, wherein Ar, n, X, Z, R1, R2 and R3 have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds which modulate protein kinase activity, specifically the activity of serum and glucocorticoid regulated kinase (SGK), in particular of serum and glucocorticoid regulated kinase isoform 1 (SGK-1, SGK1), and are suitable for the treatment of diseases in which SGK activity is inappropriate, for example degenerative joint disorders or inflammatory processes such as osteoarthritis or rheumatism. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use as pharmaceuticals, and pharmaceutical compositions comprising them.

  本发明涉及式I中的N-(4-(氮杂吲唑-6-基)-苯基)-磺酰胺，其中Ar、n、X、Z、R1、R2和R3在权利要求中指定了它们的含义。式I化合物是有价值的药理活性化合物，可以调节蛋白激酶活性，特别是血清和糖皮质激素调节激酶（SGK）的活性，特别是血清和糖皮质激素调节激酶亚型1（SGK-1，SGK1）的活性，并适用于治疗SGK活性不当的疾病，例如退行性关节疾病或炎症过程，如骨关节炎或风湿病。此外，本发明还涉及制备式I化合物的方法，它们作为药物的用途以及包含它们的制剂。
• US9718825B2
  申请人：——

  公开号：US9718825B2

  公开（公告）日：2017-08-01
• Asymmetrization of meso-1,3-diols utilising Pseudomonas fluorescens lipase
  作者：François-René Alexandre、François Huet

  DOI：10.1016/s0957-4166(98)00237-7

  日期：1998.7

  A convenient and enantioselective synthesis of monoacetates of meso-1,3-diols 2-substituted with an alkoxymethyl or a thiophenylmethyl group, by enzyme catalyzed acylation, is described. The absolute stereochemistries of two monoacetates were assigned by chemical correlation. (C) 1998 Elsevier Science Ltd. All rights reserved.